Ultherapy treatment

DEVICE2 trials

Sponsors

Ulthera, Inc, Merz North America, Inc.

Conditions

Improvement in Skin Laxity of the Lower Face and SubmentumSkin Laxity

Unknown Phase

Gene Expression Following Ultherapy® Treatment

TerminatedNCT02441036

Ulthera, IncSkin Laxity

Start: 2015-05-01End: 2016-08-18Updated: 2019-02-20

Evaluation of the Effectiveness and Safety of the Ulthera® DeepSEE® System for Treating Skin Laxity in the Lower Face and Submentum

CompletedNCT04795622

Merz North America, Inc.Improvement in Skin Laxity of the Lower Face and Submentum

Start: 2021-03-16End: 2022-05-17Updated: 2023-03-23